Hepatitis C Drug Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Published By: Zion Research<br />
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong> for (Hospitals, Private Labs, Physician<br />
Offices, Public Health Labs and Blood Banks) by Application -<br />
Global Industry Perspective, Comprehensive Analysis, Size,<br />
Share, Growth, Segment, Trends and Forecast, 2015 – 2021<br />
Joel John<br />
3422 SW 15 Street, Suit #8138,<br />
Deerfield Beach,<br />
Florida 33442, USA<br />
Tel: +1-386-310-3803<br />
Toll Free: 1-855-465-4651<br />
www.marketresearchstore.com<br />
sales@marketresearchstore.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
Zion Research has published a new report titled “<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong> for (Hospitals,<br />
Private Labs, Physician Offices, Public Health Labs and Blood Banks) by Application - Global<br />
Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021” According to the<br />
report, global demand for hepatitis C drug market was valued at USD 11.81 billion in<br />
2015, is expected to reach USD 27.63 billion in 2021 and is anticipated to grow at a<br />
CAGR of 17% between 2016 and 2021.<br />
Request Report Sample http://www.marketresearchstore.com/report/hepatitis-cdrug-market-z62423<br />
HCV is a major public health problem that attacks the liver and leads to inflammation. Certain<br />
drugs, toxins, heavy alcohol use, bacterial and viral infections can cause hepatitis infection. The<br />
most common types of hepatitis infections are <strong>Hepatitis</strong> A, <strong>Hepatitis</strong> B, and <strong>Hepatitis</strong> C and they<br />
are caused by three dissimilar dissimilar viruses. Although each virus can cause similar<br />
symptoms, they have different modes of transmission and can affect the liver differently.<br />
sales@marketresearchstore.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
<strong>Hepatitis</strong> C infection can bring both acute and chronic hepatitis disease. Approximately, 80% of<br />
patients get chronically infected with hepatitis C disease. <strong>Hepatitis</strong> C infection (HCV) spreads<br />
through the blood of infected individual by the use of shared needles or supplies used to infuse<br />
drugs. Vaccines are available only for <strong>Hepatitis</strong> A and <strong>Hepatitis</strong> B viruses. Research into the<br />
development of a vaccine for hepatitis C is under way.<br />
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong>: Inquiry<br />
for buying report http://www.marketresearchstore.com/report/hepatitis-c-drugmarket-z62423#InquiryForBuying<br />
The prevalence of the infection, new productive treatments, relatively lesser time of treatment<br />
from before, and rising government subsidizing, can drive the hepatitis C drug market. Lack of<br />
awareness and information about HCV and treatment expense of disease can influence the<br />
hepatitis C market. In the last few years a couple of new drugs have been launched in the market<br />
which has huge success and captured maximum market share of the hepatitis C market.<br />
However, cost of these drugs is too high. Hospitals, private labs, physician offices, public health<br />
labs, and blood banks are the key application of hepatitis C drug market.<br />
sales@marketresearchstore.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
North America was one of the fastest growing hepatitis C drug markets across the world with<br />
more than 40% share of the total revenue generated in 2015. U. S. is the largest revenue<br />
contributor for worldwide <strong>Hepatitis</strong> C market. Government funding for drug development will<br />
continue to play an essential role in the growth of U.S. HCV treatment market. Europe was the<br />
second major market for <strong>Hepatitis</strong> C in 2015.<br />
Ongoing research and development in pharmaceutical industry for hepatitis C drug<br />
development is expected to propel the market growth in the coming years. Moreover, interest for<br />
<strong>Hepatitis</strong> C medication is expanding in Asia Pacific, Latin America and Middle East and Africa<br />
due to prevalence of the disease in the regions combined with expenditure on healthcare<br />
infrastructure.<br />
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong>: Browse the full report<br />
at http://www.marketresearchstore.com/report/hepatitis-c-drug-market-z62423<br />
Harvoni and Sovaldi are newly discovered drugs for <strong>Hepatitis</strong> C. <strong>Market</strong>ed by pharmaceutical<br />
giant Gilead Sciences and has more than 95% cure rate. The problem with this drug is its high<br />
sales@marketresearchstore.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
cost, Harvoni drug is one of the expensive drug in the world. Some of the key player in the<br />
hepatitis C drug market includes Merck & Co, Kenilworth, Roche, Basel GlaxoSmith, Gilead<br />
Sciences, AbbVie, Johnson & Johnson and Bristol-Myers Squibb.<br />
The report segments the global hepatitis C drug market as<br />
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong>: Table of<br />
Content http://www.marketresearchstore.com/report/hepatitis-c-drug-marketz62423#tableOfContent<br />
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong>: Application Segment Analysis<br />
<br />
<br />
<br />
Hospitals<br />
Private labs<br />
Physician offices<br />
sales@marketresearchstore.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
<br />
<br />
Public health labs<br />
Blood banks<br />
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong>: Regional Segment Analysis<br />
<br />
<br />
<br />
<br />
North America<br />
o U.S.<br />
Europe<br />
o Germany<br />
o UK<br />
o France<br />
Asia Pacific<br />
o China<br />
o Japan<br />
o India<br />
Latin America<br />
o Brazil<br />
sales@marketresearchstore.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
<br />
Middle East and Africa<br />
<br />
<br />
<br />
Chapter 1. Preface<br />
o 1.1. Report description and scope<br />
o 1.2. Research scope<br />
o 1.3. Research methodology<br />
• 1.3.1. <strong>Market</strong> research process<br />
• 1.3.2. <strong>Market</strong> research methodology<br />
Chapter 2. Executive Summary<br />
o 2.1. Global hepatitis C drug market, 2015 - 2021, (USD Billion)<br />
o 2.2. <strong>Hepatitis</strong> C drug: market snapshot<br />
Chapter 3. <strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong>: Industry Analysis<br />
o<br />
o<br />
o<br />
3.1. <strong>Hepatitis</strong> C drug : <strong>Market</strong> dynamics<br />
3.2. <strong>Market</strong> Drivers<br />
• 3.2.1. Increasing incidences of the disease<br />
• 3.2.2. New efficient therapies and comparatively smaller period of treatment<br />
• 3.2.3. Rising government funding<br />
3.3. Restraints<br />
sales@marketresearchstore.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
<br />
• 3.3.1. Lack of awareness and information about HCV<br />
• 3.3.2. Treatment cost<br />
• 3.3.3. Threat related with regulation and development of drug<br />
o 3.4. Opportunity<br />
• 3.4.1. Advancing technologies and ongoing research<br />
o 3.5. Porter’s Five Forces Analysis<br />
o 3.6. <strong>Market</strong> Attractiveness Analysis<br />
• 3.6.1. <strong>Market</strong> attractiveness analysis by application segment<br />
• 3.6.2. <strong>Market</strong> attractiveness analysis by regional segment<br />
Chapter 4. Global hepatitis C drug market: Competitive Landscape<br />
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong>: Browse the full report<br />
at http://www.marketresearchstore.com/report/hepatitis-c-drug-market-z62423<br />
o<br />
o<br />
4.1. Company <strong>Market</strong> Share Analysis<br />
• 4.1.1. Global hepatitis C drug market: company market share, 2015<br />
4.2. Strategic Development<br />
• 4.2.1. Acquisitions & Mergers<br />
• 4.2.2. New Product Launch<br />
• 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures<br />
• 4.2.4. Research and Development, Product and Regional Expansion<br />
sales@marketresearchstore.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
<br />
<br />
o<br />
o<br />
4.3. Price Trend Analysis<br />
4.4. Product Portfolio<br />
o 4.5. Patent Analysis (2011-2016)<br />
• 4.5.1. Patent Trend<br />
• 4.5.2. Patent Share by company<br />
• 4.5.3. By Region<br />
Chapter 5. Global hepatitis C market: Application Overview<br />
o 5.1. Global hepatitis C drug market share, by application, 2015 and 2021<br />
o 5.2. Global hepatitis C drug market for hospitals, 2015 - 2021(USD Billion)<br />
o 5.3. Global hepatitis C drug market for private labs , 2015 - 2021 (USD Billion)<br />
o 5.4. Global hepatitis C drug market for physician offices, 2015 - 2021 (USD Billion)<br />
o 5.5. Global hepatitis C drug market for public health labs, 2015 - 2021 (USD Billion)<br />
o 5.6. Global hepatitis C drug market for blood banks, 2015 - 2021 (USD Billion)<br />
Chapter 6. Global hepatitis C drug market: Regional Analysis<br />
o<br />
o<br />
6.1. Global hepatitis C drug market: Regional overview<br />
• 6.1.1. Global hepatitis C drug market share, by region, 2015 and 2021<br />
6.2. North America<br />
• 6.2.1. North America hepatitis C drug market revenue, by application, 2015 –<br />
2021 (USD Billion)<br />
• 6.2.2. U.S.<br />
• 6.2.3. U.S. hepatitis C drug market revenue, by application, 2015 – 2021 (USD<br />
Billion)<br />
sales@marketresearchstore.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
o<br />
6.3. Europe<br />
• 6.3.1. Europe hepatitis C drug market revenue, by application, 2015 – 2021 (USD<br />
Billion)<br />
• 6.3.2. UK<br />
• 6.3.2.1. UK hepatitis C drug market revenue, by application, 2015 – 2021<br />
(USD Billion)<br />
• 6.3.3. France<br />
• 6.3.3.1. France hepatitis C drug market revenue, by application, 2015 –<br />
2021 (USD Billion)<br />
• 6.3.4. Germany<br />
• 6.3.4.1. Germany hepatitis C drug market revenue, by application, 2015 –<br />
2021 (USD Billion)<br />
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong>: Browse the full report<br />
at http://www.marketresearchstore.com/report/hepatitis-c-drug-market-z62423<br />
o<br />
6.4. Asia Pacific<br />
• 6.4.1. Asia-Pacific hepatitis C drug market revenue, by application, 2015 – 2021<br />
(USD Billion)<br />
• 6.4.2. China<br />
sales@marketresearchstore.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
<br />
• 6.4.2.1. China hepatitis C drug market revenue, by application, 2015 –<br />
2021 (USD Billion)<br />
• 6.4.3. Japan<br />
• 6.4.3.1. Japan hepatitis C drug market revenue, by application, 2015 –<br />
2021 (USD Billion)<br />
• 6.4.4. India<br />
• 6.4.4.1. India hepatitis C drug market revenue, by application, 2015 –<br />
2021 (USD Billion)<br />
o 6.5. Latin America<br />
• 6.5.1. Latin America hepatitis C drug market revenue, by application, 2015 – 2021<br />
(USD Billion)<br />
• 6.5.2. Brazil<br />
• 6.5.2.1. Brazil hepatitis C drug market revenue, by application, 2015 –<br />
2021 (USD Billion)<br />
o 6.6. Middle East & Africa<br />
• 6.6.1. Middle East & Africa hepatitis C drug market revenue, by application, 2015<br />
– 2021 (USD Billion)<br />
Chapter 7. Company Profiles<br />
o<br />
7.1. Merck & Co<br />
• 7.1.1. Overview<br />
• 7.1.2. Financials<br />
• 7.1.3. Product portfolio<br />
sales@marketresearchstore.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
o<br />
o<br />
o<br />
o<br />
• 7.1.4. Business strategy<br />
• 7.1.5. Recent developments<br />
7.2. Kenilworth<br />
• 7.2.1. Overview<br />
• 7.2.2. Financials<br />
• 7.2.3. Product portfolio<br />
• 7.2.4. Business strategy<br />
• 7.2.5. Recent developments<br />
7.3. Roche<br />
• 7.3.1. Overview<br />
• 7.3.2. Financials<br />
• 7.3.3. Product portfolio<br />
• 7.3.4. Business strategy<br />
• 7.3.5. Recent developments<br />
7.4. Basel Glaxosmith<br />
• 7.4.1. Overview<br />
• 7.4.2. Financials<br />
• 7.4.3. Product portfolio<br />
• 7.4.4. Business strategy<br />
• 7.4.5. Recent developments<br />
7.5. Gilead Sciences<br />
• 7.5.1. Overview<br />
sales@marketresearchstore.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
o<br />
o<br />
o<br />
• 7.5.2. Financials<br />
• 7.5.3. Product portfolio<br />
• 7.5.4. Business strategy<br />
• 7.5.5. Recent developments<br />
7.6. Abbvie<br />
• 7.6.1. Overview<br />
• 7.6.2. Financials<br />
• 7.6.3. Product portfolio<br />
• 7.6.4. Business strategy<br />
• 7.6.5. Recent developments<br />
7.7. Bristol- Myers Squibb.d<br />
• 7.7.1. Overview<br />
• 7.7.2. Financials<br />
• 7.7.3. Product portfolio<br />
• 7.7.4. Business strategy<br />
• 7.7.5. Recent developments<br />
7.8. Johnson & Johnson<br />
• 7.8.1. Overview<br />
• 7.8.2. Financials<br />
• 7.8.3. Product portfolio<br />
• 7.8.4. Business strategy<br />
• 7.8.5. Recent Developments<br />
sales@marketresearchstore.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
<br />
Chapter 8. Patents<br />
o 8.1. U.S. (US Patents)<br />
o 8.2. Europe (EP documents)<br />
o 8.3. Japan (Abstracts of Japan)<br />
o 8.4. Global (WIPO (PCT))<br />
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong>: Browse the full report<br />
at http://www.marketresearchstore.com/report/hepatitis-c-drug-market-z62423<br />
sales@marketresearchstore.com
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
<strong>Market</strong> Research Store<br />
Address: Suite #8138, 3422 SW 15 Street, Deerfield Beach, Florida 33442, USA<br />
Tel: +1-386-310-3803<br />
Tel: +1-855-465-4651 (US/CAN TOLL FREE)<br />
Email: sales@marketresearchstore.com<br />
Web : http://www.marketresearchstore.com<br />
sales@marketresearchstore.com